Today: 8 June 2026
Archer Aviation stock dips after a big-volume jump as Wall Street eyes FAA milestones
15 January 2026
1 min read

Archer Aviation stock dips after a big-volume jump as Wall Street eyes FAA milestones

NEW YORK, Jan 15, 2026, 09:41 EST — Regular session

  • Archer Aviation shares dipped 0.8% early on, following a 5.2% gain the previous session.
  • On Wednesday, Needham reaffirmed its buy rating and maintained a $10 price target, per GuruFocus.
  • Traders are eyeing certification progress closely, while the Nasdaq marks Feb. 26 as the tentative date for the next earnings update.

Archer Aviation Inc shares slipped 0.8% to $8.84 in early Thursday trading, giving back some of the previous day’s 5.2% jump. The stock has seen heavy action this week, with volumes exceeding 50 million shares in both of the past two sessions.

These shifts are significant since Archer remains a pre-revenue play for many investors. Its stock often jumps sharply on small signals—analyst updates, conference buzz, or any hint about how quickly regulators might weigh in. When interest rates rise or appetite for risk fades, companies like Archer, which require years to deliver, can take a swift hit.

Needham & Company stuck with its “buy” rating on Archer Wednesday, keeping the price target steady at $10, according to GuruFocus. The update came just after the stock suffered a steep decline the previous day. Analyst Chris Pierce was named in the report. GuruFocus

Archer’s management took the stage at Needham’s Growth Conference on Jan. 13. The event runs through Jan. 16, featuring both in-person and virtual sessions. This conference has become a key stop for growth investors seeking insights beyond what’s in official filings.

Archer is among a handful of firms racing to bring eVTOL aircraft—electric vertical takeoff and landing vehicles—to market, targeting short urban flights. The industry’s immediate outlook hinges on regulatory approvals, infrastructure development, and if early operations can scale beyond pilot projects.

Policy moves quietly in the background. In December, the U.S. Department of Transportation unveiled a national strategy on advanced air mobility, outlining how to fold new aircraft into U.S. airspace.

The race remains fierce, with legal battles still brewing. In November, Joby Aviation took Archer to California state court, accusing the rival of stealing trade secrets. This lawsuit could drag on as both firms race to secure certification and bring their products to market.

The downside is clear-cut: certification drags on, cash burn remains elevated, and the company ends up seeking additional funds on less favorable terms. Delays alone, even without new capital, can push back launch schedules and production goals.

Investors will probably stay focused on analyst updates and any new insights from the conference trail in the short term. At the same time, they’ll track daily liquidity and volume closely, searching for clues whether this recent surge is losing steam or attracting fresh buying interest.

Archer’s next major event is earnings, currently pegged for Feb. 26 on Nasdaq’s calendar. That date, however, isn’t set in stone as companies often adjust their reporting schedules.

Stock Market Today

  • Rocket Lab (RKLB) Might Outshine SpaceX IPO for Investors
    June 8, 2026, 3:00 AM EDT. SpaceX is set for a historic IPO on June 12 with a $2 trillion valuation, priced at 107 times its 2025 sales. Despite 33% revenue growth, SpaceX posts heavy losses due to its AI and rocket divisions, with a $4.3 billion net loss in Q1 2026. The IPO is already oversubscribed twice and includes up to 30% shares for retail investors, raising caution. Conversely, Rocket Lab (NASDAQ: RKLB), a smaller space company focusing on reusable rockets, grew revenue by 38% to $602 million in 2025, with smaller losses relative to SpaceX. It holds key government contracts and aims to expand offerings. Investors might consider RKLB as a less risky, faster-growing alternative to SpaceX's overvalued and loss-heavy IPO.

Latest articles

Snap Drops 5%—Ad Recovery Eyed Next

Snap Drops 5%—Ad Recovery Eyed Next

8 June 2026
Snap closed Friday at $5.76, down 5.11% amid a broad tech selloff triggered by a strong jobs report and renewed rate-hike worries, but still ended the week up 0.9%. Investors now await U.S. inflation data and CEO Evan Spiegel’s June 16 AWE keynote on Specs, as Snap faces pressure from weak North American ad revenue, tough competition, and activist demands for cost cuts.
Navitas’ Nvidia-Led Rally Stalls, Eyes on AI Trade Next Week

Navitas’ Nvidia-Led Rally Stalls, Eyes on AI Trade Next Week

8 June 2026
Navitas plunged $5.61 to $25.08 Friday as a $1.3 trillion chip selloff erased Nvidia-driven gains, despite news it issued 3.28 million shares for merger earn-outs and showcased its GaNFast power board at Nvidia’s AI MGX event; investors now face risks from share dilution, sector volatility, and Navitas’s early-stage pivot to high-power AI markets amid ongoing operating losses.
NIO Stock Drops Even as Deliveries Jump, Focus Turns to June Numbers

NIO Stock Drops Even as Deliveries Jump, Focus Turns to June Numbers

8 June 2026
NIO’s U.S.-listed shares plunged 5.8% Friday, erasing a delivery-led rally, as investors focus on whether June sales can hit the company’s Q2 target after May deliveries rose 62.3% to 37,705. NIO needs 42,939–47,939 June deliveries to meet guidance, with risks from China’s saturated car market and recent price pressure.
HPE Stock Faces AI Rally Test With Monday In Focus

HPE Stock Faces AI Rally Test With Monday In Focus

8 June 2026
Hewlett Packard Enterprise plunged 8.36% Friday to $49.20, capping a three-day slide and erasing gains after a post-earnings surge, even as it raised its fiscal 2026 revenue growth outlook to 29%-33% and boosted non-GAAP EPS guidance, with analysts warning that rapid gains may have priced in too much hope too quickly.
POET Technologies stock climbs before the bell as call-option volume spikes
Previous Story

POET Technologies stock climbs before the bell as call-option volume spikes

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead
Next Story

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead

Go toTop